• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

    12/6/23 7:00:00 AM ET
    $ASPI
    $AYTU
    $CIA
    $CING
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASPI alert in real time by email

    MIAMI, Dec. 06, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 65th Emerging Growth Conference on December 6th and 7th, 2023.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - December 6, 2023

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    ATRenew Inc. (NYSE:RERE)

    Keynote speakers: Jeremy Ji, Director of Corporate Development & Jessie Jin, Investor Relations Manager

    10:15 - 10:45

    Helo Corp (OTC:HLOC)

    Keynote speaker: Sean McVeigh, CEO & CFO

    10:50 - 11:20

    Fieldpoint Equity

    Keynote speakers: Owen T. Carhart, General Partner, Parker Evans, General Partner and Daniel Campana, General Partner 

    11:25 - 11:55

    Catheter Precision, Inc. (NYSE:VTAK)

    Keynote speaker: David Jenkins, Executive Chairman & Interim CEO

    12:00 - 12:30

    Spectra7 Microsystems Inc. (OTCQB:SPVNF) (TSXV:SEV)

    Keynote speaker: Raouf Youssef Halim, CEO

    1:10 - 1:40

    Coeptis Therapeutics Holdings, Inc., (NASDAQ:COEP)

    Keynote speaker: David Mehalick, President / CEO

    1:45 - 2:15

    Starco Brands (OTCQB:STCB)

    Keynote speaker: Ross Sklar, CEO

    2:20 – 2:50

    Cingulate Inc. (NASDAQ:CING)

    Keynote speaker: Shane Schaffer, CEO

    2:55 - 3:05

    Gold Terra Resource Corp. (OTCQX:YGTFF) (TSXV:YGT)

    Keynote speaker: Gerald Sylvain Panneton, CEO

    3:10 - 3:20

    Theriva Biologics Inc., (NYSE:TOVX)

    Keynote speaker: Dr. Manel Cascallo, General Director

    3:25 - 3:35

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    3:40 - 3:50

    Quantum Computing Inc., (NASDAQ:QUBT)

    Keynote speakers: Robert Liscouski, CEO, & Chris Boehmler, CFO

    3:55 - 4:05

    Steppe Gold, Ltd. (OTCQX:STPGF) (TSX:STGO)

    Keynote speakers: Aneel Singh, Exec. VP & Director

    4:10 - 4:20

    Medicus Pharma, Ltd. (TSXV:MDCX)

    Keynote speaker: Carolyn Bonner, President

    Day 2 - December 7, 2023

    9:20

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    9:40 - 10:10

    Pherousa Green Technologies AS

    Keynote speaker: Hans Bredrup, Chairman & Partner, and Vasilis Besikiotis, Founder & Technical Director

    10:15 - 10:45

    Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH)

    Keynote speaker: Anatoly Dritschilo, MD, CEO & Chairman

    10:50 - 11:20

    ASP Isotopes, Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    11:25 - 11:55

    Pulsar Helium, Inc.'s (TSXV:PLSR)

    Keynote speaker: Thomas Abraham-James President / CEO

    12:00 - 12:30

    Intellicheck (NASDAQ:IDN)

    Keynote speaker: Bryan Lewis, President / CEO & Director

    12:35 - 1:05

    Forum Energy Technologies Inc (NYSE:FET)

    Keynote speakers: Neal A. Lux, President / CEO & Director, Lyle Williams, CFO, and Rob Kukla, Director of Investor Relations

    1:10 - 1:40

    Aytu BioPharma (NASDAQ:AYTU)

    Keynote speaker: Joshua Disbrow, Chairman, CEO

    1:45 - 2:15

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    2:20 - 2:50

    Intelligent Bio Solutions Inc. (NASDAQ:INBS)

    Keynote speaker: Harry Simeonidis, President / CEO

    Postponed to January

    Citizens, Inc. (NYSE:CIA)

    Keynote speaker: Gerald W. Shields, Vice Chairman / CEO, and Jeff Conklin, CFO

    3:10 - 3:20

    FendX Technologies, Inc. (OTCQB:FDXTF) (CSE:FNDX)

    Keynote speaker: Carolyn Jane Myers, CEO

    3:25 - 3:35

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speaker: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant

    3:40 - 3:50

    BioLargo, Inc. (OTCQB:BLGO)

    Keynote speaker: Dennis Calvert, President / CEO

    3:55 - 4:05

    Global Crossing Airlines Group, Inc. (OTCQB:JETMF)

    Keynote speaker: Ryan Goepel, EVP & CFO

    4:10 – 4:20

    Battery Mineral Resources Corp., (OTCQB:BTRMF) (TSXV:BMR)

    Keynote speaker: Martin Kostuik, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPI
    $AYTU
    $CIA
    $CING

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Quantum Computing Inc.
    $QUBT
    1/15/2026$22.00Buy
    Rosenblatt
    Quantum Computing Inc.
    $QUBT
    12/17/2025$12.00Neutral
    Wedbush
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Intellicheck Inc.
    $IDN
    11/13/2025$7.00Market Perform → Outperform
    Northland Capital
    Quantum Computing Inc.
    $QUBT
    9/18/2025$24.00Buy
    Lake Street
    Quantum Computing Inc.
    $QUBT
    7/2/2025$15.00Neutral
    Cantor Fitzgerald
    Aytu BioPharma Inc.
    $AYTU
    7/1/2025$8.00Buy
    Lake Street
    More analyst ratings

    $ASPI
    $AYTU
    $CIA
    $CING
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & CHO Danford Michael Dewayne covered exercise/tax liability with 8,208 shares and converted options into 20,479 shares, increasing direct ownership by 30% to 52,681 units (SEC Form 4)

    4 - FORUM ENERGY TECHNOLOGIES, INC. (0001401257) (Issuer)

    2/19/26 9:40:04 AM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    President & CEO Lux Neal converted options into 157,710 shares and covered exercise/tax liability with 62,162 shares, increasing direct ownership by 44% to 311,276 units (SEC Form 4)

    4 - FORUM ENERGY TECHNOLOGIES, INC. (0001401257) (Issuer)

    2/19/26 9:39:03 AM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    SVP Brookes Mark converted options into 14,461 shares and covered exercise/tax liability with 3,673 shares, increasing direct ownership by 92% to 22,547 units (SEC Form 4)

    4 - FORUM ENERGY TECHNOLOGIES, INC. (0001401257) (Issuer)

    2/19/26 9:38:04 AM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    $ASPI
    $AYTU
    $CIA
    $CING
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rosenblatt initiated coverage on Quantum Computing with a new price target

    Rosenblatt initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $22.00

    1/15/26 8:40:11 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Wedbush initiated coverage on Quantum Computing with a new price target

    Wedbush initiated coverage of Quantum Computing with a rating of Neutral and set a new price target of $12.00

    12/17/25 9:27:03 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $ASPI
    $AYTU
    $CIA
    $CING
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP and CFO Callahan Jennifer L. bought $24,515 worth of shares (4,864 units at $5.04), increasing direct ownership by 2,494% to 5,059 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:20 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Schaffer Shane J. bought $34,317 worth of shares (6,809 units at $5.04) (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:19 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Werth Peter J. bought $98,053 worth of shares (19,455 units at $5.04) (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:20 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CING
    SEC Filings

    View All

    ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ASP Isotopes Inc. (0001921865) (Filer)

    2/19/26 9:25:32 AM ET
    $ASPI
    Major Chemicals
    Industrials

    SEC Form PRE 14A filed by Cingulate Inc.

    PRE 14A - Cingulate Inc. (0001862150) (Filer)

    2/18/26 4:05:55 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Theriva Biologics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Theriva Biologics, Inc. (0000894158) (Filer)

    2/18/26 8:10:34 AM ET
    $TOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CING
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Forum Energy Technologies Announces Fourth Quarter and Full Year 2025 Results and Outlook; Repurchased 11% of Shares Outstanding in 2025

    Fourth Quarter 2025 Highlights Revenue: $202 million Net income and adjusted net income: $2 million and $5 million, respectively Adjusted EBITDA: $23 million Operating cash flow and free cash flow: $22 million and $22 million, respectively Full Year 2025 Highlights Orders: $891 million, book-to-bill ratio of 113% Operating cash flow and free cash flow: $70 million and $80 million, respectively Share repurchases: 1.4 million shares, returned $35 million to shareholders Full Year 2026 Guidance (comparisons at midpoint) Revenue: $800 - $880 million, up 6% Adjusted net income: $18 - $38 million, up $21 million Adjusted EBITDA: $90 - $110 million, a 16% incre

    2/19/26 5:46:00 PM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum

    DENVER, Feb. 19, 2026 (GLOBE NEWSWIRE) -- U.S. equity markets are pointing modestly lower this Thursday morning. The focus remains on earnings season kickoff and any fresh Fed commentary, but today's headlines are dominated by transformative deals and production milestones that are lifting small- and mid-cap names. Key Movers & Catalysts Driving the Tape Interactive Strength (NASDAQ:TRNR) is the standout gainer pre-market, surging more than 40% after announcing a definitive agreement to acquire Ergatta, the game-based connected fitness pioneer. The deal boosts TRNR's 2026 pro forma revenue guidance by 50%, to more than $30 million, with Ergatta alone expected to deliver > $10 million in

    2/19/26 11:00:26 AM ET
    $ELAB
    $TOVX
    $TRNR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Consumer Electronics/Appliances
    Technology

    Post-Quantum Cryptography Migration Is Now a Trillion-Dollar Imperative

    VANCOUVER, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – A single quantum-enabled cyberattack on a major U.S. bank could trigger $2.0 to $3.3 trillion in economic damage, according to a February report by the Citi Institute[1]. Global cybersecurity spending is projected to reach $244.2 billion in 2026, with post-quantum cryptography migration among six forces Gartner identified as reshaping enterprise security architecture[2]. That urgency is driving momentum for Quantum Secure Encryption Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN8), Arqit Quantum Inc. (NASDAQ:ARQQ), IonQ, Inc. (NYSE:IONQ), Quantum Computing Inc. (NASDAQ:QUBT), and Rigetti Computi

    2/19/26 9:30:00 AM ET
    $ARQQ
    $IONQ
    $QUBT
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    $ASPI
    $AYTU
    $CIA
    $CING
    Leadership Updates

    Live Leadership Updates

    View All

    Forum Energy Technologies Announces Appointment of The Honorable Leslie A. Beyer to its Board of Directors

    Forum Energy Technologies, Inc. (NYSE:FET) today announced the appointment of The Honorable Leslie A. Beyer to its Board of Directors. Ms. Beyer will also serve as a member of the Compensation & Human Capital Committee and the Nominating, Governance & Sustainability Committee. Ms. Beyer is the former Assistant Secretary of the Interior for Land and Minerals Management at the U.S. Department of Interior. Prior to that, Ms. Beyer served as Chief Executive Officer of the Energy Workforce and Technology Council (EWTC), the global energy technology and services association representing over 650,000 employees in the energy workforce. Before joining the EWTC, Ms. Beyer spent 15 years in Washingt

    1/12/26 8:00:00 AM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    Quantum Computing Inc. Confirms Dr. Yuping Huang as Chief Executive Officer to Lead Global Growth

    HOBOKEN, N.J., Dec. 17, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced a leadership update with the appointment of Dr. Yuping Huang as Chief Executive Officer ("CEO"), effective January 1st, 2026. Dr. Huang was appointed as QCi's Interim CEO on April 11, 2025. This appointment comes as part of QCi's ongoing focus on growth and scaling its quantum photonics systems for industrial and commercial use. Dr. Huang's appointment marks a pivotal moment as QCi moves from prototype development and small-batch manufacturing toward industrial-scale manufacturing production. The

    12/17/25 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Shuttle Pharmaceuticals Acquires AI Health Platform

    Rockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition of the assets and liabilities of 1542770 B.C. Ltd. d/b/a Molecule.ai ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, 1563868 B.C. Ltd., a wholly owned subsidiary of Shuttle, acquired substantially all of Molecule's assets and liabilities for a total purchase price of $8 million, payable in a combination of cash and shares of Shuttle common stock, plus an additional contingent $2 million, pay

    11/21/25 9:30:00 AM ET
    $SHPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CING
    Financials

    Live finance-specific insights

    View All

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Quantum Speed Technology Targeting Multi-Trillion-Dollar Infrastructure Efficiency Opportunity

    Advanced computing power positions companies to unlock cost savings across global energy, transportation, and logistics networksNEW YORK, Feb. 17, 2026 /CNW/ -- Market News Updates News Commentary - Quantum speed is all about solving really big problems much faster than traditional computers. For large-scale infrastructure -- think power grids, transportation systems, or supply chains -- there are millions of data points and interconnected moving parts. Classical computers can tackle this complexity, but it often takes a long time. Quantum-powered systems, by contrast, can evaluate many possibilities at once, helping planners and operators find smarter solutions in a fraction of the time. Th

    2/17/26 9:00:00 AM ET
    $IONQ
    $LAZR
    $QBTS
    EDP Services
    Technology
    Auto Parts:O.E.M.
    Consumer Discretionary

    Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

    First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year  Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, including $9.40 million receivable in connection with the private placement of securities that closed on January 2, 2026. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, no

    2/12/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $ASPI
    $AYTU
    $CIA
    $CING
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Intellicheck Inc.

    SC 13G/A - Intellicheck, Inc. (0001040896) (Subject)

    11/15/24 7:00:49 AM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Intelligent Bio Solutions Inc.

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 7:16:17 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care